10: Management of obesity

Medical Journal of Australia

Volumn 180, Issue 9, 2004, Pages 474-480

  Proietto, Joseph ^a,b   Baur, Louise A ^c  

^a HEIDELBERG REPATRIATION HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; AMYLIN; ANTIOBESITY AGENT; AOD 9604; ATORVASTATIN; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; GLIBENCLAMIDE; GROWTH HORMONE DERIVATIVE; LEPTIN; METFORMIN; PAROXETINE; PHENTERMINE; RAMIPRIL; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TOPIRAMATE; UNCLASSIFIED DRUG; VENLAFAXINE;

AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BARIATRIC SURGERY; CALORIC INTAKE; CLINICAL TRIAL; COMORBIDITY; DRUG USE; DYSLIPIDEMIA; EPIDEMIC; GENETIC PREDISPOSITION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDIVIDUALIZATION; LIFESTYLE; MUSCULOSKELETAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; TREATMENT PLANNING;

EID: 2442452754     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2004.tb06031.x     Document Type: Article

References (42)

1. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164-1171.
2. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, 3-5 June 1997. Geneva: WHO, 1998.
3. Ko GT, Tang J, Chan JC, et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 2000; 85: 239-242.
4. Swinburn BA, Ley SJ, Carmichael HE, et al. Body size and composition in Polynesians. Int J Obes Relat Metab Disord 1999; 23: 1178-1183.
5. Han TS, Van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-1405.
6. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 8: 1-27.
7. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: NHMRC, 2003.
8. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
9. Maffeis C, Pietrobelli A, Grezzani A, et al. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001; 9: 179-187.
10. Goran MI. Gower BA. Relation between visceral fat and disease risk in children and adolescents. Am J Clin Nutr 1999; 70: S149-S156.
11. National Heart Foundation of Australia. Risk factor prevalence study No 1. 1980 Canberra: NHF, 1980
12. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab) Med J Aust 2003; 178: 427-432.
13. Magarey AM, Daniels LA, Boulton TJ. Prevalence of overweight and obesity in Australian children and adolescents: reassessment of 1985 and 1995 data against new standard international definitions. Med J Aust 2001; 174: 561-564.
14. Stunkard AJ, Harris JR, Pedersen NL, et al. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-1487.
15. Sorensen TI, Holst C, Stunkard AJ, et al. Correlations of body mass index of adult adoptees and their biological and adoptive relatives. Int J Obes Relat Metab Disord 1992; 16: 227-236.
16. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics 2002; 2: 177-187.
17. Robinson TN. Television viewing and childhood obesity. Pediatr Clin North Am 2001; 48: 1017-1025.
18. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 2001; 357: 505-508.
19. Jeffery RW. Minnesota studies on community-based approaches to weight loss and control. Ann Intern Med 1993; 119: 719-721.
20. Campbell K, Waters E, O'Meara S, et al. Interventions for preventing obesity in children. Cochrane Database Syst Rev 2002, CD001871.
21. Economos CD, Brownson RC, DeAngelis MA, et al. What lessons have been learned from other attempts to guide social change? Nutrition Reviews 2001; 59: S40-S56.
22. Ludwig DS, Pereira MA, Kroenke CH, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999; 282: 1539-1546.
23. Brand-Miller J, Foster-Powell K, Colagiuri S. The new glucose revolution. 2nd ed. Sydney: Hodder Headline Australia, 2003.
24. Harvey EL, Glenny A-M, Kirk SFL, Summerbell CD. Improving health professionals' management and the organisation of care for overweight and obese people (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley and Sons, Ltd.
25. Epstein LH, Valoski A, Wing RR, et al. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264: 2519-2523.
26. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol 1982; 50: 950-971.
27. Golan M, Weizman A, Apter A, et al. Parents as the exclusive agents of change in the treatment of childhood obesity. Am J Clin Nutr 1998; 67: 1130-1135.
28. Summerbell CD, Waters E, Edmunds L, et al. Interventions for treating obesity in children (protocol for a Cochrane review). The Cochrane Library, 2003. Oxford: Update Software.
29. Brownell KD, Kelman JH, Stunkard AJ. Treatment of obese children with and without their mothers: changes in weight and blood pressure. Pediatrics 1983; 71: 515-523.
30. Saelens BE, Sallis JF, Wilfley DE, et al. Behavioral weight control for overweight adolescents initiated in primary care. Obes Res 2002; 10: 22-32.
31. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in children. Canberra: NHMRC, 2003. Available at: www.obesityguidelines.gov.au (accessed Mar 2004).
32. Burry JN. Obesity and virtue. Is staying lean a matter of ethics? Med J Aust 1999; 171: 609-610
33. Scheen AJ. Results of obesity treatment. Ann Endocrinol (Paris) 2002; 63: 163-170.
34. Geldszus R, Mayr B, Horn R, et al. Serum leptin and weight reduction in female obesity. Eur J Endocrinol 1996; 135: 659-662.
35. Montague CT, Farooqi IS, Whitewhead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
36. Haddock CK, Poston WS, Dill PL. et al. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes 2002; 26: 262-273.
37. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-161.
38. James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-2125.
39. Dixon JB, O'Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002; 184: 51S-54S.
40. Sjostrom L. Obesity, diabetes and other cardiovascular risk factors: lessons from SOS. Int J Obes 2000; 24: S7.
41. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-363.
42. Allen JW, Coleman MG, Fielding GA. Lessons learned from laparoscopic gastric banding for morbid obesity. Am J Surg 2001; 182: 10-14.